Autopsy report · NCT03126097

A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study stopping rules were met.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 month before it stopped.
18 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Janssen Research & Development, LLC
Sponsor type: Industry
Conditions: Healthy
Interventions: JNJ-64155806 150 mg; Ethinylestradiol/drospirenone 0.02 mg/3 mg; COCP Placebo
Participants: 18
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.